APO Research
Talk to an analyst

APO RESEARCH · REPORT

EMOCAP

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global EMOCAP Market Outlook and Growth Opportunities 2026

4 June 2026202 pages

Choose your research edition.

Industry ResearchEMOCAP Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal EMOCAP Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal EMOCAP Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal EMOCAP Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal EMOCAP Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global EMOCAP market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the EMOCAP market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the EMOCAP market include StretchSense, Noitom, Vicon, Cyber Glove Systems, Rokoko, MANUS, AiQ Synertial, Virtual Motion Labs and PhaseSpace, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global EMOCAP market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of EMOCAP and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents EMOCAP revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global EMOCAP market.

EMOCAP Segment by Company

StretchSense

Noitom

Vicon

Cyber Glove Systems

Rokoko

MANUS

AiQ Synertial

Virtual Motion Labs

PhaseSpace

VRTRIX

HaptX

Virdyn

Qualisys AB

Xsens Technologyes

Optitrack

Codamotion

PTI Phoenix Technologies

Noraxon USA

NTT Data

EMOCAP Segment by Type

Whole Boby

Part Boby

EMOCAP Segment by Application

Scientific Research

Entertainment

Medical

Other

EMOCAP Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global EMOCAP status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the EMOCAP key companies, revenue, market share, and recent developments.

3. To split the EMOCAP breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions EMOCAP market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify EMOCAP significant trends, drivers, influence factors in global and regions.

6. To analyze EMOCAP competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EMOCAP market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EMOCAP and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EMOCAP.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global EMOCAP industry.

Chapter 3: Detailed analysis of EMOCAP company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of EMOCAP in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of EMOCAP in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. EMOCAP Industry Trends Table 2. EMOCAP Industry Drivers Table 3. EMOCAP Industry Opportunities and Challenges Table 4. EMOCAP Industry Restraints Table 5. Global EMOCAP Revenue by Company (US$ Million) & (2021-2026) Table 6. Global EMOCAP Revenue Share by Company (2021-2026) Table 7. Global EMOCAP Company Ranking, (2024-2026) & (US$ Million) Table 8. Global EMOCAP Key Company Manufacturing Base & Headquarters Table 9. Global EMOCAP Company, Product Type & Application Table 10. Global EMOCAP Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global EMOCAP by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Whole Boby Table 15. Significant Companies of Part Boby Table 16. Global EMOCAP Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global EMOCAP Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global EMOCAP Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global EMOCAP Sales Value Share by Type (2021-2026) Table 20. Global EMOCAP Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Scientific Research Table 22. Significant Companies of Entertainment Table 23. Significant Companies of Medical Table 24. Significant Companies of Other Table 25. Global EMOCAP Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global EMOCAP Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global EMOCAP Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global EMOCAP Sales Value Share by Application (2021-2026) Table 29. Global EMOCAP Sales Value Share by Application (2027-2032) Table 30. Global EMOCAP Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global EMOCAP Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global EMOCAP Sales Value Share by Region (2021-2026) Table 33. Global EMOCAP Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global EMOCAP Sales Value Share by Region (2027-2032) Table 35. Global EMOCAP Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global EMOCAP Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global EMOCAP Sales Value Market Share by Country (2021-2026) Table 38. Global EMOCAP Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global EMOCAP Sales Value Market Share by Country (2027-2032) Table 40. StretchSense Company Information Table 41. StretchSense Business Overview Table 42. StretchSense EMOCAP Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. StretchSense EMOCAP Product Portfolio Table 44. StretchSense Recent Development Table 45. Noitom Company Information Table 46. Noitom Business Overview Table 47. Noitom EMOCAP Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Noitom EMOCAP Product Portfolio Table 49. Noitom Recent Development Table 50. Vicon Company Information Table 51. Vicon Business Overview Table 52. Vicon EMOCAP Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Vicon EMOCAP Product Portfolio Table 54. Vicon Recent Development Table 55. Cyber Glove Systems Company Information Table 56. Cyber Glove Systems Business Overview Table 57. Cyber Glove Systems EMOCAP Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Cyber Glove Systems EMOCAP Product Portfolio Table 59. Cyber Glove Systems Recent Development Table 60. Rokoko Company Information Table 61. Rokoko Business Overview Table 62. Rokoko EMOCAP Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Rokoko EMOCAP Product Portfolio Table 64. Rokoko Recent Development Table 65. MANUS Company Information Table 66. MANUS Business Overview Table 67. MANUS EMOCAP Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. MANUS EMOCAP Product Portfolio Table 69. MANUS Recent Development Table 70. AiQ Synertial Company Information Table 71. AiQ Synertial Business Overview Table 72. AiQ Synertial EMOCAP Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. AiQ Synertial EMOCAP Product Portfolio Table 74. AiQ Synertial Recent Development Table 75. Virtual Motion Labs Company Information Table 76. Virtual Motion Labs Business Overview Table 77. Virtual Motion Labs EMOCAP Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Virtual Motion Labs EMOCAP Product Portfolio Table 79. Virtual Motion Labs Recent Development Table 80. PhaseSpace Company Information Table 81. PhaseSpace Business Overview Table 82. PhaseSpace EMOCAP Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. PhaseSpace EMOCAP Product Portfolio Table 84. PhaseSpace Recent Development Table 85. VRTRIX Company Information Table 86. VRTRIX Business Overview Table 87. VRTRIX EMOCAP Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. VRTRIX EMOCAP Product Portfolio Table 89. VRTRIX Recent Development Table 90. HaptX Company Information Table 91. HaptX Business Overview Table 92. HaptX EMOCAP Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. HaptX EMOCAP Product Portfolio Table 94. HaptX Recent Development Table 95. Virdyn Company Information Table 96. Virdyn Business Overview Table 97. Virdyn EMOCAP Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Virdyn EMOCAP Product Portfolio Table 99. Virdyn Recent Development Table 100. Qualisys AB Company Information Table 101. Qualisys AB Business Overview Table 102. Qualisys AB EMOCAP Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Qualisys AB EMOCAP Product Portfolio Table 104. Qualisys AB Recent Development Table 105. Xsens Technologyes Company Information Table 106. Xsens Technologyes Business Overview Table 107. Xsens Technologyes EMOCAP Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Xsens Technologyes EMOCAP Product Portfolio Table 109. Xsens Technologyes Recent Development Table 110. Optitrack Company Information Table 111. Optitrack Business Overview Table 112. Optitrack EMOCAP Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Optitrack EMOCAP Product Portfolio Table 114. Optitrack Recent Development Table 115. Codamotion Company Information Table 116. Codamotion Business Overview Table 117. Codamotion EMOCAP Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Codamotion EMOCAP Product Portfolio Table 119. Codamotion Recent Development Table 120. PTI Phoenix Technologies Company Information Table 121. PTI Phoenix Technologies Business Overview Table 122. PTI Phoenix Technologies EMOCAP Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. PTI Phoenix Technologies EMOCAP Product Portfolio Table 124. PTI Phoenix Technologies Recent Development Table 125. Noraxon USA Company Information Table 126. Noraxon USA Business Overview Table 127. Noraxon USA EMOCAP Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Noraxon USA EMOCAP Product Portfolio Table 129. Noraxon USA Recent Development Table 130. NTT Data Company Information Table 131. NTT Data Business Overview Table 132. NTT Data EMOCAP Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. NTT Data EMOCAP Product Portfolio Table 134. NTT Data Recent Development Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. EMOCAP Product Image Figure 2. Global EMOCAP Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EMOCAP Market Size (2021-2032) & (US$ Million) Figure 4. Global EMOCAP Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Whole Boby Image Figure 8. Part Boby Image Figure 9. Global EMOCAP Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global EMOCAP Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global EMOCAP Sales Value Share by Type (2021-2032) Figure 12. Scientific Research Image Figure 13. Entertainment Image Figure 14. Medical Image Figure 15. Other Image Figure 16. Global EMOCAP Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global EMOCAP Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global EMOCAP Sales Value Share by Application (2021-2032) Figure 19. Global EMOCAP Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global EMOCAP Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America EMOCAP Sales Value (2021-2032) & (US$ Million) Figure 22. North America EMOCAP Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe EMOCAP Sales Value (2021-2032) & (US$ Million) Figure 24. Europe EMOCAP Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific EMOCAP Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific EMOCAP Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America EMOCAP Sales Value (2021-2032) & (US$ Million) Figure 28. South America EMOCAP Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa EMOCAP Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa EMOCAP Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt EMOCAP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt EMOCAP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt EMOCAP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Whole Boby
  • Part Boby
Applications
  • Scientific Research
  • Entertainment
  • Medical
  • Other
Companies covered
  • StretchSense
  • Noitom
  • Vicon
  • Cyber Glove Systems
  • Rokoko
  • MANUS
  • AiQ Synertial
  • Virtual Motion Labs
  • PhaseSpace
  • VRTRIX
  • HaptX
  • Virdyn
  • Qualisys AB
  • Xsens Technologyes
  • Optitrack
  • Codamotion
  • PTI Phoenix Technologies
  • Noraxon USA
  • NTT Data

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global EMOCAP Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global EMOCAP Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 EMOCAP Market Dynamics
  1. 2.1 EMOCAP Industry Trends
  2. 2.2 EMOCAP Industry Drivers
  3. 2.3 EMOCAP Industry Opportunities and Challenges
  4. 2.4 EMOCAP Industry Restraints
3 EMOCAP Market by Company
  1. 3.1 Global EMOCAP Company Revenue Ranking in 2025
  2. 3.2 Global EMOCAP Revenue by Company (2021-2026)
  3. 3.3 Global EMOCAP Company Ranking (2024-2026)
  4. 3.4 Global EMOCAP Company Manufacturing Base and Headquarters
  5. 3.5 Global EMOCAP Company Product Type and Application
  6. 3.6 Global EMOCAP Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global EMOCAP Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 EMOCAP Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 EMOCAP Market by Type
  1. 4.1 EMOCAP Type Introduction
  2. 4.1.1 Whole Boby
  3. 4.1.2 Part Boby
  4. 4.2 Global EMOCAP Sales Value by Type
  5. 4.2.1 Global EMOCAP Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global EMOCAP Sales Value by Type (2021-2032)
  7. 4.2.3 Global EMOCAP Sales Value Share by Type (2021-2032)
5 EMOCAP Market by Application
  1. 5.1 EMOCAP Application Introduction
  2. 5.1.1 Scientific Research
  3. 5.1.2 Entertainment
  4. 5.1.3 Medical
  5. 5.1.4 Other
  6. 5.2 Global EMOCAP Sales Value by Application
  7. 5.2.1 Global EMOCAP Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global EMOCAP Sales Value by Application (2021-2032)
  9. 5.2.3 Global EMOCAP Sales Value Share by Application (2021-2032)
6 EMOCAP Regional Value Analysis
  1. 6.1 Global EMOCAP Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global EMOCAP Sales Value by Region (2021-2032)
  3. 6.2.1 Global EMOCAP Sales Value by Region: 2021-2026
  4. 6.2.2 Global EMOCAP Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America EMOCAP Sales Value (2021-2032)
  7. 6.3.2 North America EMOCAP Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe EMOCAP Sales Value (2021-2032)
  10. 6.4.2 Europe EMOCAP Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific EMOCAP Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific EMOCAP Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America EMOCAP Sales Value (2021-2032)
  16. 6.6.2 South America EMOCAP Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa EMOCAP Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa EMOCAP Sales Value Share by Country, 2025 VS 2032
7 EMOCAP Country-level Value Analysis
  1. 7.1 Global EMOCAP Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global EMOCAP Sales Value by Country (2021-2032)
  3. 7.2.1 Global EMOCAP Sales Value by Country (2021-2026)
  4. 7.2.2 Global EMOCAP Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA EMOCAP Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA EMOCAP Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA EMOCAP Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada EMOCAP Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada EMOCAP Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada EMOCAP Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico EMOCAP Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico EMOCAP Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico EMOCAP Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany EMOCAP Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany EMOCAP Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany EMOCAP Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France EMOCAP Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France EMOCAP Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France EMOCAP Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. EMOCAP Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. EMOCAP Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. EMOCAP Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy EMOCAP Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy EMOCAP Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy EMOCAP Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain EMOCAP Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain EMOCAP Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain EMOCAP Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia EMOCAP Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia EMOCAP Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia EMOCAP Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands EMOCAP Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands EMOCAP Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands EMOCAP Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries EMOCAP Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries EMOCAP Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries EMOCAP Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China EMOCAP Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China EMOCAP Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China EMOCAP Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan EMOCAP Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan EMOCAP Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan EMOCAP Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea EMOCAP Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea EMOCAP Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea EMOCAP Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India EMOCAP Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India EMOCAP Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India EMOCAP Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia EMOCAP Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia EMOCAP Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia EMOCAP Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia EMOCAP Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia EMOCAP Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia EMOCAP Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil EMOCAP Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil EMOCAP Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil EMOCAP Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina EMOCAP Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina EMOCAP Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina EMOCAP Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile EMOCAP Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile EMOCAP Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile EMOCAP Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia EMOCAP Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia EMOCAP Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia EMOCAP Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru EMOCAP Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru EMOCAP Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru EMOCAP Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia EMOCAP Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia EMOCAP Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia EMOCAP Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel EMOCAP Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel EMOCAP Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel EMOCAP Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE EMOCAP Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE EMOCAP Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE EMOCAP Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey EMOCAP Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey EMOCAP Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey EMOCAP Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran EMOCAP Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran EMOCAP Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran EMOCAP Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt EMOCAP Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt EMOCAP Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt EMOCAP Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 StretchSense
  2. 8.1.1 StretchSense Company Information
  3. 8.1.2 StretchSense Business Overview
  4. 8.1.3 StretchSense EMOCAP Revenue and Gross Margin (2021-2026)
  5. 8.1.4 StretchSense EMOCAP Product Portfolio
  6. 8.1.5 StretchSense Recent Developments
  7. 8.2 Noitom
  8. 8.2.1 Noitom Company Information
  9. 8.2.2 Noitom Business Overview
  10. 8.2.3 Noitom EMOCAP Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Noitom EMOCAP Product Portfolio
  12. 8.2.5 Noitom Recent Developments
  13. 8.3 Vicon
  14. 8.3.1 Vicon Company Information
  15. 8.3.2 Vicon Business Overview
  16. 8.3.3 Vicon EMOCAP Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Vicon EMOCAP Product Portfolio
  18. 8.3.5 Vicon Recent Developments
  19. 8.4 Cyber Glove Systems
  20. 8.4.1 Cyber Glove Systems Company Information
  21. 8.4.2 Cyber Glove Systems Business Overview
  22. 8.4.3 Cyber Glove Systems EMOCAP Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cyber Glove Systems EMOCAP Product Portfolio
  24. 8.4.5 Cyber Glove Systems Recent Developments
  25. 8.5 Rokoko
  26. 8.5.1 Rokoko Company Information
  27. 8.5.2 Rokoko Business Overview
  28. 8.5.3 Rokoko EMOCAP Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Rokoko EMOCAP Product Portfolio
  30. 8.5.5 Rokoko Recent Developments
  31. 8.6 MANUS
  32. 8.6.1 MANUS Company Information
  33. 8.6.2 MANUS Business Overview
  34. 8.6.3 MANUS EMOCAP Revenue and Gross Margin (2021-2026)
  35. 8.6.4 MANUS EMOCAP Product Portfolio
  36. 8.6.5 MANUS Recent Developments
  37. 8.7 AiQ Synertial
  38. 8.7.1 AiQ Synertial Company Information
  39. 8.7.2 AiQ Synertial Business Overview
  40. 8.7.3 AiQ Synertial EMOCAP Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AiQ Synertial EMOCAP Product Portfolio
  42. 8.7.5 AiQ Synertial Recent Developments
  43. 8.8 Virtual Motion Labs
  44. 8.8.1 Virtual Motion Labs Company Information
  45. 8.8.2 Virtual Motion Labs Business Overview
  46. 8.8.3 Virtual Motion Labs EMOCAP Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Virtual Motion Labs EMOCAP Product Portfolio
  48. 8.8.5 Virtual Motion Labs Recent Developments
  49. 8.9 PhaseSpace
  50. 8.9.1 PhaseSpace Company Information
  51. 8.9.2 PhaseSpace Business Overview
  52. 8.9.3 PhaseSpace EMOCAP Revenue and Gross Margin (2021-2026)
  53. 8.9.4 PhaseSpace EMOCAP Product Portfolio
  54. 8.9.5 PhaseSpace Recent Developments
  55. 8.10 VRTRIX
  56. 8.10.1 VRTRIX Company Information
  57. 8.10.2 VRTRIX Business Overview
  58. 8.10.3 VRTRIX EMOCAP Revenue and Gross Margin (2021-2026)
  59. 8.10.4 VRTRIX EMOCAP Product Portfolio
  60. 8.10.5 VRTRIX Recent Developments
  61. 8.11 HaptX
  62. 8.11.1 HaptX Company Information
  63. 8.11.2 HaptX Business Overview
  64. 8.11.3 HaptX EMOCAP Revenue and Gross Margin (2021-2026)
  65. 8.11.4 HaptX EMOCAP Product Portfolio
  66. 8.11.5 HaptX Recent Developments
  67. 8.12 Virdyn
  68. 8.12.1 Virdyn Company Information
  69. 8.12.2 Virdyn Business Overview
  70. 8.12.3 Virdyn EMOCAP Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Virdyn EMOCAP Product Portfolio
  72. 8.12.5 Virdyn Recent Developments
  73. 8.13 Qualisys AB
  74. 8.13.1 Qualisys AB Company Information
  75. 8.13.2 Qualisys AB Business Overview
  76. 8.13.3 Qualisys AB EMOCAP Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Qualisys AB EMOCAP Product Portfolio
  78. 8.13.5 Qualisys AB Recent Developments
  79. 8.14 Xsens Technologyes
  80. 8.14.1 Xsens Technologyes Company Information
  81. 8.14.2 Xsens Technologyes Business Overview
  82. 8.14.3 Xsens Technologyes EMOCAP Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Xsens Technologyes EMOCAP Product Portfolio
  84. 8.14.5 Xsens Technologyes Recent Developments
  85. 8.15 Optitrack
  86. 8.15.1 Optitrack Company Information
  87. 8.15.2 Optitrack Business Overview
  88. 8.15.3 Optitrack EMOCAP Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Optitrack EMOCAP Product Portfolio
  90. 8.15.5 Optitrack Recent Developments
  91. 8.16 Codamotion
  92. 8.16.1 Codamotion Company Information
  93. 8.16.2 Codamotion Business Overview
  94. 8.16.3 Codamotion EMOCAP Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Codamotion EMOCAP Product Portfolio
  96. 8.16.5 Codamotion Recent Developments
  97. 8.17 PTI Phoenix Technologies
  98. 8.17.1 PTI Phoenix Technologies Company Information
  99. 8.17.2 PTI Phoenix Technologies Business Overview
  100. 8.17.3 PTI Phoenix Technologies EMOCAP Revenue and Gross Margin (2021-2026)
  101. 8.17.4 PTI Phoenix Technologies EMOCAP Product Portfolio
  102. 8.17.5 PTI Phoenix Technologies Recent Developments
  103. 8.18 Noraxon USA
  104. 8.18.1 Noraxon USA Company Information
  105. 8.18.2 Noraxon USA Business Overview
  106. 8.18.3 Noraxon USA EMOCAP Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Noraxon USA EMOCAP Product Portfolio
  108. 8.18.5 Noraxon USA Recent Developments
  109. 8.19 NTT Data
  110. 8.19.1 NTT Data Company Information
  111. 8.19.2 NTT Data Business Overview
  112. 8.19.3 NTT Data EMOCAP Revenue and Gross Margin (2021-2026)
  113. 8.19.4 NTT Data EMOCAP Product Portfolio
  114. 8.19.5 NTT Data Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst